SELLAS Life Sciences (SLS) Capital Expenditures Growth (5y) (2015 - 2016)

SELLAS Life Sciences (SLS) Capital Expenditures Growth (5y) (2015 - 2016) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,561.01 Bn	66,560.72 Bn	-
2	Nanobiotix	1,911.11 Bn	1,911.05 Bn	-
3	Akari Therapeutics	1,009.43 Bn	1,009.43 Bn	-
4	BeOne Medicines	467.81 Bn	463.02 Bn	1.35 Bn
5	Vertex Pharmaceuticals	122.92 Bn	115.68 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.28 Bn	61.53 Bn	3.31 Bn
7	Belite Bio	62.88 Bn	62.88 Bn	-
8	Argenx Se	55.90 Bn	50.72 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.53 Bn	34.52 Bn	959.66 Mn
10	SELLAS Life Sciences	1.93 Bn	1.83 Bn	-

Download Data